bupivacaine has been researched along with interleukin-8 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bar-Meir, S; Bassani, L; Chowers, Y; Fidder, H; Lahav, M; Lang, A; Levite, M; Mayer, L; Tal, R | 1 |
Beier, JP; Guillaume, VGJ; Lippold, EF; Ruhl, T | 1 |
2 other study(ies) available for bupivacaine and interleukin-8
Article | Year |
---|---|
Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells.
Topics: Adenocarcinoma; Anesthetics, Local; Bupivacaine; Colitis, Ulcerative; Colonic Neoplasms; Epithelial Cells; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Intestinal Mucosa; Lidocaine; RNA, Messenger; Sialoglycoproteins; Tetracaine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Comprehensive Analysis of Local Anesthetics Affecting Adipose Stem Cells In Vitro.
Topics: Amides; Anesthetics, Local; Bupivacaine; Hepatocyte Growth Factor; Humans; Interleukin-8; Lidocaine; Mepivacaine; Ropivacaine; Stem Cells; Vascular Endothelial Growth Factor A | 2023 |